Viewing Study NCT01589302


Ignite Creation Date: 2025-12-25 @ 3:56 AM
Ignite Modification Date: 2025-12-26 @ 2:47 AM
Study NCT ID: NCT01589302
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-25
First Post: 2012-04-23
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia
Sponsor: Kami Maddocks, MD
Organization: